IndiaNapless, IN, United States
IndiaNapless, IN, United States

Eli Lilly and Company is an American global pharmaceutical company with headquarters located in Indianapolis, Indiana, in the United States. The company also has offices in Puerto Rico and 17 other countries. Their products are sold in approximately 125 countries. The company was founded in 1876 by Col. Eli Lilly, a pharmaceutical chemist and veteran of the American Civil War, after whom the company was named.Among other specialties, Lilly was the first company to mass-produce penicillin, the Salk polio vaccine, and insulin, including one of the first pharmaceutical companies to produce human insulin using recombinant DNA. Lilly is also the world's largest manufacturer and distributor of psychiatric medications. In 2009, Eli Lilly pleaded guilty to illegally marketing the drug Zyprexa for off-label uses not approved by the U.S. Food and Drug Administration, particularly the treatment of dementia in the elderly. The company paid a $515 million criminal fine, at the time the largest in history. Wikipedia.


Time filter

Source Type

Patent
Eli Lilly and Company | Date: 2016-08-19

The invention is a pharmaceutical composition of human insulin or insulin analog that includes citrate, treprostinil and stabilizing agents, that has faster pharmacokinetic and/or pharmacodynamic action than commercial formulations of existing insulin analog products and that is stable for commercial use.


Patent
Eli Lilly and Company | Date: 2016-04-06

The present invention relates to compounds of formula I: or pharmaceutically acceptable acid addition salts thereof, where; The compounds of the present invention are useful for activating 5-HT_(1F )receptors, inhibiting neuronal protein extravasation, and for the treatment or prevention of migraine in a mammal. The present invention also relates to a process for the synthesis of intermediates in the synthesis of compounds of Formula I.


Patent
Eli Lilly and Company | Date: 2016-08-05

The present invention provides a compound of Formula II: or a pharmaceutically acceptable salt thereof.


Patent
Eli Lilly and Company | Date: 2016-08-05

The present invention provides a compound of Formula II: or a pharmaceutically acceptable salt thereof.


Patent
Eli Lilly and Company | Date: 2016-11-02

The present invention provides human engineered calcitonin gene related peptide (CGRP) antibodies or antigen-binding fragment thereof. In addition, the present invention provides the use of the human engineered calcitonin gene related peptide (CGRP) antibodies or antigen-binding fragment thereof for the treatment of osteoarthritis pain.


Patent
Eli Lilly and Company | Date: 2016-08-22

The present invention relates to compounds that inhibit activity of the histone lysine methyltransferase, Enhancer of Zeste Homolog 2 (EZH2), pharmaceutical compositions comprising the compounds, and methods of using the compounds to treat cancer, such as hematologic and solid tumors.


Patent
Eli Lilly and Company | Date: 2016-09-06

The present invention provides novel ROR gamma-t inhibitors and pharmaceutical compositions thereof:


Patent
Eli Lilly and Company | Date: 2016-07-28

The present invention relates to certain benzimidazole compounds, or pharmaceutically acceptable salts thereof, that inhibit Janus kinase 1 (JAK1), pharmaceutical compositions comprising the compounds, and methods of using the compounds to treat certain types of cancer.


Patent
Eli Lilly and Company | Date: 2016-08-18

The present invention relates to antibodies that bind human programmed cell death 1 ligand 1 (PD-L1), and may be useful for treating solid and hematological tumors alone and in combination with chemotherapy and other cancer therapeutics.


Patent
Washington University in St. Louis, Eli Lilly and Company | Date: 2017-04-05

A method to treat conditions characterized by formation of amyloid plaques both grophylactically and therapeutically is described. The method employs humanized antibodies which sequester soluble A peptide from human biological fluids or which preferably specifically bind an epitope contained within position 13-28 of the amyloid beta peptide A.

Loading Eli Lilly and Company collaborators
Loading Eli Lilly and Company collaborators